{
    "answer": "For the full year 2024, Novartis reported immunology segment net sales of $50.3 billion and $50.32 billion for constant currency basis, compared to $50.21 billion (reported) and $49.39 billion (constant currency) in 2023. These results were a change of +0.19% (reported) and +1.32% (constant currency) compared to 2023.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 5,
    "search count": 4,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        929,
        2370,
        3726,
        5253,
        6740
    ]
}